Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/28/14  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Stephen C. Owings

Wrong Stephen C. Owings?

Board Member

Phone: (404) ***-****  HQ Phone
Road Safe America
P.O. Box 191502
Atlanta, Georgia 31119
United States

Company Description: Road Safe America has identified numerous changes that will make our highways much safer. Our top priorities are as follows: Require all heavy commercial trucks...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • Bachelor of Science Degree
    Northern Arizona University
175 Total References
Web References
Preventing Trucking Accidents and Semi Truck Accidents
www.roadsafeamerica.org, 28 Mar 2014 [cached]
Steve Owings
...
Stephen Owings
Preventing Trucking Accidents and Semi Truck Accidents
www.roadsafeamerica.org, 28 Mar 2014 [cached]
Concerned Americans Advocating Roadway Safety (CAAIRS), the precursor to Road Safe America (RSA) is founded by Steve and Susan Owings
...
Road Safe America produces a video for distribution, Steve and Susan are interviewed by WGST
...
Steve Owings is appointed to the Motor Carrier Safety Advisory Committee to the FMCSA (Federal Motor Carrier Safety Administration)
...
Steve Owings is re-appointed to the congressional advisory committee of FMCSA (Federal Motor Carrier Safety Administration) Steve Owings speaks at the National Press Club in D.C.
...
Northwestern Mutual Financial Network honors Steve Owings with the top prize for philanthropic agents for his efforts with Road Safe America
...
Steve Owings, Co-Founder of Road Safe America is asked by US Senate Commerce Committee to provide comments regarding highway safety.
Investor Relations Sequenom - News Releases
sequenom.investorroom.com [cached]
Sequenom Names Steven Owings Vice President of Commercial Development, Prenatal Diagnostics
"About half the people on the ...
www.etrucker.com, 29 Oct 2014 [cached]
"About half the people on the committee felt like they were not comfortable with the final product," noted MCSAC Chairman Stephen Owings at the opening of the MCSAC's October 28 meeting.
Sequenom Names Steven Owings Vice President of Commercial Development, Prenatal Diagnostics - Feb 5, 2007
sequenom.investorroom.com, 5 Feb 2007 [cached]
Sequenom Names Steven Owings Vice President of Commercial Development, Prenatal Diagnostics Sequenom Names Steven Owings Vice President of Commercial Development, Prenatal Diagnostics - Feb 5, 2007
...
Sequenom Names Steven Owings Vice President of Commercial Development, Prenatal Diagnostics
PRNewswire-FirstCall SAN DIEGO Feb 5, 2007
Sequenom, Inc. (NASDAQ: SQNM) today announced that it has named Steven Owings to the newly created position of Vice-President of Commercial Development, Prenatal Diagnostics. Mr. Owings will lead the Company's commercialization of its non-invasive prenatal diagnostic technology currently under development. The Company expects application of its non-invasive technology for fetal Rhesus D (RhD) typing to first become available through a licensed clinical laboratory during the first half of this year.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO )
"Steve is ideal for this position as he brings a breadth of diagnostic commercialization and sales leadership experience to Sequenom, including a history of successful genomic test launches," said Harry Stylli, Ph.D., President and Chief Executive Officer.
...
"Sequenom's non-invasive approach to prenatal genetic testing has the potential to create a paradigm shift away from highly invasive procedures, such as amniocentesis, that pose risk to both mother and child," said Mr. Owings. "Joining Sequenom at this time provides an exciting opportunity for me to apply my industry experience and passion for introducing novel technology."
Mr. Owings brings to Sequenom more than 28 years of business leadership experience in the diagnostics and biotechnology industries. For nearly 20 years, Mr. Owings held various managerial and sales positions at Roche Diagnostic Systems. From 1992 to 1997, as Director of the PCR Business Unit, U.S., he assisted in transitioning PCR technology from research laboratory use to commercial laboratories, hospitals and healthcare providers nationwide. Through innovative marketing efforts, such as the creation and implementation of third-party reimbursement strategies and patient assistance programs, he facilitated the successful launch of the company's first FDA-approved PCR test for Chlamydia trachomatis and first FDA-approved test to measure the amount of virus in an HIV/AIDS patient's blood.
During his tenure at Digene Corporation, as Vice President of Sales and Marketing, Mr. Owings helped launch the first FDA approved HPV assay into the clinical diagnostics market. Mr. Owings also served as Vice President, Sales and Marketing for Visible Genetics Inc., purchased by Bayer Diagnostics in 2002. At Visible Genetics Mr. Owings lead the North and Latin American sales and marketing teams and was instrumental in the launch of the first fully integrated FDA-cleared genomic device for the assessment of HIV drug resistance. Most recently, he served as President, North America, of Primagen Inc., a privately held molecular diagnostics company, where he developed licensing agreements with major diagnostic and laboratory service organizations.
Mr. Owings holds a Bachelor of Science Degree from Northern Arizona University.
...
Except for the historical information contained in this press release, the matters set forth herein, including statements regarding Sequenom's commercialization of its non-invasive prenatal diagnostic technology, expected application of Sequenom's non-invasive technology for fetal Rhesus D typing and its availability during the first half of this year, the future contributions of Mr. Owings to Sequenom and the opportunity for Mr. Owings, Sequenom's work to build a non-invasive prenatal diagnostic franchise, create value, and maximize commercial opportunities, the potential of Sequenom's non-invasive approach to prenatal genetic testing to create a paradigm shift away from highly invasive procedures, and Sequenom's plans to develop and commercialize non-invasive prenatal genetic tests for use with the MassARRAY system and other platforms, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, as amended.
Other People with the name "Owings":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304